v3.26.1
Capital Stock (Tables)
3 Months Ended
Mar. 31, 2026
Equity [Abstract]  
Schedule of Company’s Common Stock Purchase Warrants

A continuity schedule of the Company’s outstanding common stock purchase warrants for the three months ended March 31, 2026, is as follows:

 

   Number of
Warrants
   Weighted Average
Exercise Price
   Weighted Average
Remaining Contractual Life (Years)
 
Balance at December 31 2025   1,740,992   $13.00    0.31 
Exercised   (8,333)   13.00      
Balance at March 31, 2026   1,732,659   $13.00    0.07 
Schedule of Weighted Average Basis Assumption Used in the Black-Scholes Option Pricing Model

 

       
   Three Months Ended March 31, 
   2026   2025 
Risk Free Interest Rate   3.43%   - 
Expected Life in Years   3.00    - 
Expected Volatility   66.13%   - 
Expected Dividend Yield   0.00%   - 
Estimated forfeiture rate   0.00%   - 
Schedule of Stock Option Activity

The following table summarizes the Company’s stock option activity:

 

   Number of
Stock Options
   Weighted Average
Exercise Price
 
Balance at December 31, 2025   425,300   $9.79 
Granted   10,000    11.67 
Forfeited   (5,800)   9.79 
Balance at March 31, 2026   429,500   $9.84 
Schedule of RSUs Activity

The following table summarizes the Company’s RSUs activity:

 

   Number of RSUs   Weighted Average
Grant-Date Fair Value
 
Balance at December 31, 2025   19,950   $9.12 
Vested   (5,175)   9.36 
Forfeited   (500)   9.40 
Balance at March 31, 2026   14,275   $9.02